<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04477317</url>
  </required_header>
  <id_info>
    <org_study_id>local anesthesia in chilldren</org_study_id>
    <nct_id>NCT04477317</nct_id>
  </id_info>
  <brief_title>Anesthetic Efficacy of %4Alexadricaine Versus %2 Mepicaine-L in Children</brief_title>
  <official_title>Anesthetic Efficacy of %4Alexadricaine Versus %2 Mepicaine-L for Infiltration Anesthesia in Extraction of Maxillary First Primary Molars in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to evaluate and compare the anesthetic efficacy of&#xD;
      Alexadricaine versus Mepecaine-L infiltration anesthesia in children during extraction of&#xD;
      badly decayed or unrestorable maxillary first primary molars.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To our knowledge, no clinical trials in literature have been done to compare anesthetic&#xD;
      efficacy of 4% Articaine versus 2% Mepivacaine in pain management during extraction of badly&#xD;
      decayed upper first primary molars. Thus, the purpose of the present study was to fill this&#xD;
      knowledge gap.&#xD;
&#xD;
      This trial will be held on a new brand of 4% articaine made in Egypt called Alexadricaine&#xD;
      anesthetic solution where no clinical trials have been conducted on it yet in literature.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2021</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intra-operative pain during extraction</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>measured by Visual Analogue Scale (VAS) and Sound Eye Motor (SEM) scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>onset of anesthesia</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>measured in minutes using stopwatch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of anesthesia</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>measured in minutes using stopwatch</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Local Anesthesia</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4% Articaine Hydrochloride with 1:100,000 Adrenaline (Alexadricaine, Alexandria Co., Egypt).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2% Mepivacaine Hydrochloride with 1:20,000 Levonordefrin (Mepicaine-L, Alexandria Co., Egypt)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>4% Articaine Hydrochloride with 1:100,000 Adrenaline</intervention_name>
    <description>new Egyptian articane anesthetic solution.</description>
    <arm_group_label>Experimental</arm_group_label>
    <other_name>%4 Alexadricaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2% Mepivacaine Hydrochloride with 1:20,000 Levonordefrin</intervention_name>
    <description>Mepecaine-L is the brand name of the Egyptian 2% Mepivacaine. It is the most commonly used anesthetic solution in Egypt due to its availability and its lower cost.</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>2% Mepicaine-L</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Medically fit (ASA I, II).&#xD;
&#xD;
          -  Mentally capable of communication.&#xD;
&#xD;
          -  Children aged 5-7 years, children older than 8 years old will not be included due to&#xD;
             physiologic root resorption associated with shedding which may simplify the extraction&#xD;
             procedure(25).&#xD;
&#xD;
          -  First maxillary primary molar needs extraction due to root caries &quot;beyond possible&#xD;
             repair&quot;.&#xD;
&#xD;
          -  First dental visit.&#xD;
&#xD;
          -  Child must give assent prior to participation, as well as approved parental informed&#xD;
             written consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children with acute or sub-acute dento-alveolar abscess Children with history of&#xD;
             prolonged bleeding, platelet disorders, Hyperthyroidism or hypersensitivity.&#xD;
&#xD;
          -  Patients who had taken analgesics or antibiotics in the 12-hrs preceding the&#xD;
             injection.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sara A mahmoud, Assoc. Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ghada MM Mahmoud, B.Sc. 2016</last_name>
    <phone>2001118705861</phone>
    <email>ghada.mostafa@dentistry.cu.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sara A mahmoud, Assoc. Prof.</last_name>
    <phone>2001000042564</phone>
    <email>saraahmed@dentistry.cu.edu.eg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculty of dentistry cairo university</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 13, 2020</study_first_submitted>
  <study_first_submitted_qc>July 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2020</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Ghada Mohamed Mostafa Mahmoud</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Nordefrin</mesh_term>
    <mesh_term>Mepivacaine</mesh_term>
    <mesh_term>Carticaine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

